Lactobacillus paracasei feeding improves the control of secondary experimental meningococcal infection in flu-infected mice.

Our data highlight the role of the gut-lung axis. L. paracasei CNCM I-1518 may boost the defence against IAV infection and secondary bacterial infection, which should be further studied and validated in clinical trials.